Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study

被引:25
作者
Gao, Liang [1 ]
Zhang, Yaju [2 ]
Wang, Xingmin [3 ]
Dong, Hongli [4 ]
机构
[1] Nantong Univ, Affiliated Matern & Child Hlth Care Hosp, Dept Clin Lab, Nantong 226018, Jiangsu, Peoples R China
[2] Nantong Univ, Affiliated Tradit Chinese Med Hosp, Finance Sect, Nantong 226018, Jiangsu, Peoples R China
[3] Nantong Univ, Affiliated Matern & Child Hlth Care Hosp, Nantong Inst Genet & Reprod Med, Nantong 226018, Jiangsu, Peoples R China
[4] Nantong Univ, Affiliated Matern & Child Hlth Care Hosp, Sci Educ Sect, Nantong 226018, Jiangsu, Peoples R China
关键词
Apolipoprotein A1; Apolipoprotein B; A1; ratio; Type; 2; diabetes; Fasting blood glucose; INSULIN-RESISTANCE; LIPOPROTEIN CHOLESTEROL; APO-B; RISK; METABOLISM; PREDICTION; MELLITUS; OBESITY; LIPIDS; WOMEN;
D O I
10.1186/s12902-021-00726-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Apolipoprotein (Apo) may be associated with type 2 diabetes (T2D), however, little is known whether or not serum apolipoproteins are correlated with fasting blood glucose (FBG) and the prevalence of T2D in Chinese populations. In this study, we examined the association of serum ApoA1, ApoB, and the ratio of ApoB/ApoA1 (ApoB/A1 ratio) with T2D and FBG level, and compared apolipoprotein indicators in predicting T2D in Chinese adults. Methods A total of 1027 subjects were enrolled in this cross-sectional study. The association of ApoA1, ApoB, and ApoB/A1 ratio with T2D prevalence was determined using logistic regression models. Multivariate-analysis of covariance (ANCOVA) was performed for comparisons of the mean difference in FBG level. Results We found that ApoB and ApoB/A1 ratio were positively associated with T2D prevalence and FBG, while inverse association was noted between ApoA1 and T2D prevalence as well as FBG. Stratified analyses for sex, age, body mass index (BMI), smoking, and alcohol consumption showed no significant difference for the association of ApoA1, ApoB, and ApoB/A1 ratio with the prevalence of T2D among subgroups (all p-interactions> 0.05). Nonetheless, ApoA1 poorly performed in predicting T2D as it provided an AUC value of 0.310 that was significantly lower than those observed for ApoB (AUC value: 0.631) and ApoB/A1 ratio (AUC value: 0.685). Finally, path analyses indicated that the association between ApoB and T2D was mediated by BMI. Conclusions This study reveals the association of serum ApoA1, ApoB, and ApoB/A1 ratio with T2D and FBG in Chinese adults, suggesting that ApoB and ApoB/A1 ratio may be early indicators for predicting T2D. Prospective investigation in large cohort is needed.
引用
收藏
页数:11
相关论文
共 58 条
  • [1] Familial defective apolipoprotein B-100: A review
    Andersen, Lars H.
    Miserez, Andre R.
    Ahmad, Zahid
    Andersen, Rolf L.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (06) : 1297 - 1302
  • [2] [Anonymous], 1981, CHINESE MED J-PEKING
  • [3] [Anonymous], 2019, IDF Diabetes Atlas, V9th
  • [4] THE MODERATOR MEDIATOR VARIABLE DISTINCTION IN SOCIAL PSYCHOLOGICAL-RESEARCH - CONCEPTUAL, STRATEGIC, AND STATISTICAL CONSIDERATIONS
    BARON, RM
    KENNY, DA
    [J]. JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1986, 51 (06) : 1173 - 1182
  • [5] Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
    Barter, PJ
    Ballantyne, CM
    Carmena, R
    Cabezas, MC
    Chapman, MJ
    Couture, P
    De Graaf, J
    Durrington, PN
    Faergeman, O
    Frohlich, J
    Furberg, CD
    Gagne, C
    Haffner, SM
    Humphries, SE
    Jungner, I
    Krauss, RM
    Kwiterovich, P
    Marcovina, S
    Packard, CJ
    Pearson, TA
    Reddy, KS
    Rosenson, R
    Sarrafzadegan, N
    Sniderman, AD
    Stalenhoef, AF
    Stein, E
    Talmud, PJ
    Tonkin, AM
    Walldius, G
    Williams, KMS
    [J]. JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) : 247 - 258
  • [6] Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study
    Brahimaj, Adela
    Ligthart, Symen
    Ikram, M. Arfan
    Hofman, Albert
    Franco, Oscar H.
    Sijbrands, Eric J. G.
    Kavousi, Maryam
    Dehghan, Abbas
    [J]. DIABETES CARE, 2017, 40 (03) : 346 - 351
  • [7] Lipoprotein management in patients with cardiometabolic risk
    Brunzell, John D.
    Davidson, Michael
    Furberg, Curt D.
    Goldberg, Ronald B.
    Howard, Barbara V.
    Stein, James H.
    Witztum, Joseph L.
    [J]. DIABETES CARE, 2008, 31 (04) : 811 - 822
  • [8] Hyperglycaemia, oxidative stress and inflammatory markers
    Butkowski, Eugene G.
    Jelinek, Herbert F.
    [J]. REDOX REPORT, 2017, 22 (06) : 257 - 264
  • [9] Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity
    Chen, Elizabeth Suchi
    Mazzotti, Diego Robles
    Furuya, Tatiane Katsue
    Cendoroglo, Maysa Seabra
    Ramos, Luiz Roberto
    Araujo, Lara Quirino
    Burbano, Rommel Rodriguez
    Cardoso Smith, Marilia de Arruda
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2009, 9 (04) : 319 - 325
  • [10] Endogenous ApoA-I expression in macrophages: A potential target for protection against atherosclerosis
    Chen, Wujun
    Wu, Yudong
    Lu, Qi
    Wang, Shuai
    Xing, Dongming
    [J]. CLINICA CHIMICA ACTA, 2020, 505 : 55 - 59